10:22 AM EST, 01/05/2026 (MT Newswires) -- CeriBell ( CBLL ) said Monday that its device for detecting large vessel occlusion stroke in a hospital setting has received a breakthrough device designation from the US Food and Drug Administration.

The company said the device uses its existing hardware and applies an artificial intelligence-based algorithm to interpret electroencephalography signals.

CeriBell ( CBLL ) shares were up 4% in recent Monday trading.

Price: 22.15, Change: +0.85, Percent Change: +3.99